Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 19:14:1825-1838.
doi: 10.2147/COPD.S178948. eCollection 2019.

Measuring and monitoring skeletal muscle function in COPD: current perspectives

Affiliations
Review

Measuring and monitoring skeletal muscle function in COPD: current perspectives

Sarah Marklund et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Skeletal muscle dysfunction is an important systemic consequence of chronic obstructive pulmonary disease (COPD) that worsens the natural cause of the disease. Up to a third of all people with COPD express some form of impairment which encompasses reductions in strength and endurance, as well as an increased fatigability. Considering this complexity, no single test could be used to measure and monitor all aspects of the impaired skeletal muscle function within the COPD population, resulting in a wide range of available tests and measurement techniques. The aim of the current review is to highlight current and new perspectives relevant to skeletal muscle function measurements within the COPD population in order to provide guidance for researchers as well as for clinicians. First of all, standardized and clinically feasible measurement protocols, as well as normative values and predictive equations across the spectrum of impaired function in COPD, are needed before assessment of skeletal muscle function can become a reality in clinical praxis. This should minimally target the quadriceps muscle; however, depending on the objective of measurements, eg, to determine upper limb muscle function or walking capacity, other muscles could also be tested. Furthermore, even though muscle strength measurements are important, current evidence suggests that other aspects, such as the endurance and power capacity of the muscle, should also be considered. Moreover, although static (isometric) measurements have been favored, dynamic measurements of skeletal muscle function should not be neglected as they, in a larger extent than static measurements, are related to tasks of daily living. Lastly, the often modest relationships between functional tests and skeletal muscle function measurements indicate that they evaluate different constructs and thus cannot replace one another. Therefore, for accurate measurements of skeletal muscle function in people with COPD, specific and formal measurements should still be prioritized.

Keywords: chronic obstructive pulmonary disease; measurement properties; muscle endurance; muscle power; muscle strength.

PubMed Disclaimer

Conflict of interest statement

Dr Andre Nyberg reports grants from Swedish Research Council, Swedish Heart and Lung Foundation, Swedish Heart and Lung Association, Strategic Research Area in Care Sciences, Harald Jeanssons Stiftelse samt Harald och Greta Jeanssons Stiftelse, Erika och Rudolf Gustavssons fond, Insamlingsstiftelsen and personal fees from AstraZeneca, outside the submitted work. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Overview of etiological factors, morphological and structural abnormalities and impaired skeletal muscle function in chronic obstructive pulmonary disease.
Figure 2
Figure 2
Factors that influence the choice of the measurement technique.

References

    1. Maltais F, Decramer M, Casaburi R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–e62. doi:10.1164/rccm.201402-0373ST - DOI - PMC - PubMed
    1. Barreiro E, Bustamante V, Cejudo P, et al. Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease. Arch Bronconeumol. 2015;51(8):384–395. doi:10.1016/j.arbres.2015.04.011 - DOI - PubMed
    1. Seymour JM, Spruit MA, Hopkinson NS, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81–88. doi:10.1183/09031936.00104909 - DOI - PMC - PubMed
    1. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10(2):417–423. - PubMed
    1. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153:976–980. doi:10.1164/ajrccm.153.3.8630582 - DOI - PubMed